Our Work

We are inspired by companies, researchers and entrepreneurs who want to make a true difference We work with great clients and great people. Catalyze supports a variety of Life Sciences developments including, but not limited to, diagnostics, pharmaceuticals, medical devices and healthcare solutions. Our clients range from researchers at academic hospitals and universities, to non-profit organizations, start-ups,… Continue Reading

€ 1.9 million for new diagnostic Lyme test

€ 1.9 million for new diagnostic Lyme test

The ID-LYME project that will bring a novel Lyme Borreliosis test to the market, was awarded a 1.9 million grant by the Horizon 2020 Fast Track to Innovation scheme.

MedEye

MedEye

The large diversity in medication and the growing amounts, require a delicate and precise distribution process.

Grant for Rare disease research

Grant for Rare disease research

For a rare condition like CPVT, an inherited cardiac arrhythmia syndrome with a prevalence of 1 in 10,000 that causes sudden cardiac death, therapies are not always accessible. Catalyze wrote a proposal for a consortium led by the Academisch Medisch Centrum in Amsterdam, resulting in an ERA-Net E-Rare grant.

Grant for research rare mitochondrial disease

Grant for research rare mitochondrial disease

A ZonMW PM-RARE grant of € 3.0 million was awarded to a national consortium consisting of the RUNMC, Khondrion BV (Nijmegen), Mercachem BV (Nijmegen) and three mitochondrial patient organizations (VSN, ESN and IMP). Catalyze was responsible for writing the proposal.